955928-57-1

Basic information

• Product Name: 3'-({4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}methyl)-N-(-ethylpiperidin-3-yl)-2-methylbiphenyl-4-carboxamide
• Synonyms: 3'-({4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}methyl)-N-(-ethylpiperidin-3-yl)-2-methylbiphenyl-4-carboxamide
• CAS NO: 955928-57-1
• Molecular Weight: 542.635
• Mol File: 955928-57-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3'-({4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}methyl)-N-(-ethylpiperidin-3-yl)-2-methylbiphenyl-4-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3'-({4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}methyl)-N-(-ethylpiperidin-3-yl)-2-methylbiphenyl-4-carboxamide(955928-57-1)
• EPA Substance Registry System: 3'-({4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}methyl)-N-(-ethylpiperidin-3-yl)-2-methylbiphenyl-4-carboxamide(955928-57-1)

Safety Data

• Hazardous Substances Data: 955928-57-1(Hazardous Substances Data)

Upstream product

• 6789-94-2 1-ethylpiperidin-3-amine 
• 955930-51-5 3'-({4-[(3,5-Dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy}methyl)-2-methylbiphenyl-4-carboxylic acid 

Relevant articles and documents

OXADIAZOLIDINEDIONE COMPOUND

[Problem] A compound which can be used as a pharmaceutical, particularly a insulin secretion promoter or a agent for preventing/treating disease in which GPR40 is concerned such as diabetes or the like, is provided. [Means for resolution] It was found that an oxadiazolidinedione compound which is characterized by the possession of a benzyl or the like substituent binding to the cyclic group via a linker at the 2-position of the oxadiazolidinedione ring, or a pharmaceutically acceptable salt thereof, has excellent GPR40 agonist action. In addition, since the oxadiazolidinedione compound of the present invention showed excellent insulin secretion promoting action and blood glucose level-lowering action, it is useful as an insulin secretion promoter or an agent for preventing/treating diabetes.